Evidence map›Paper›PMID 33317582›Full record

ArticleRadiation oncology (London, England)2020

Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : Melanoma brain metastases prognostic score.

Jana Schaule, Stephanie G C Kroeze, Oliver Blanck, Susanne Stera, Klaus H Kahl, Falk Roeder, Stephanie E Combs, David Kaul, An Claes, Markus M Schymalla and 11 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Radiation oncology (London, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors.

Jana SchauleDepartment of Radiation Oncology, University Hospital Zurich, Zurich, Switzerland. jana.schaule@uk-erlangen.de.
Stephanie G C KroezeDepartment of Radiation Oncology, University Hospital Zurich, Zurich, Switzerland.
Oliver BlanckDepartment of Radiation Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany.
Susanne SteraDepartment of Radiation Oncology, University Hospital Frankfurt, Frankfurt, Germany.
Klaus H KahlDepartment of Radiation Oncology, Universitätsklinikum Augsburg, Augsburg, Germany.
Falk RoederDepartment of Radiation Oncology, University Hospital Munich, Munich, Germany.
Stephanie E CombsDepartment of Radiation Oncology, Technical University Munich (TUM), Munich, Germany.
David KaulDepartment of Radiation Oncology, Charité-University Hospital Berlin, Berlin, Germany.
An ClaesDepartment of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.
Markus M SchymallaDepartment of Radiation Oncology, Philipps-University Marburg, Marburg, Germany.
Sonja AdebahrDepartment of Radiation Oncology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.
Franziska EckertDepartment of Radiation Oncology, Eberhard Karls Universität Tübingen, Tübingen, Germany.
Fabian LohausGerman Cancer Research Center (DKFZ), Heidelberg, Germany.
Nasrin Abbasi-SengerDepartment of Radiation Oncology, University Hospital Jena, Jena, Germany.
Guido HenkeDepartment of Radiation Oncology, Kantonsspital St. Gallen, St. Gallen, Switzerland.
Marcella SzuecsDepartment of Radiation Oncology, University Hospital Rostock, Rostock, Germany.
Michael GeierDepartment of Radiation Oncology, Ordensklinikum Linz, Linz, Austria.
Nora SundahlDepartment of Radiation Oncology, Ghent University Hospital, Ghent, Belgium.
Daniel BuergyDepartment of Radiation Oncology, Universitätsmedizin Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Reinhard DummerDepartment of Dermatology, University Hospital Zurich, University Zurich, Zurich, Switzerland.
Matthias GuckenbergerDepartment of Radiation Oncology, University Hospital Zurich, Zurich, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID33317582
PMCPMC7734768

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.